超声引导下射频消融术治疗肝癌术后局部复发因素分析

doi:10.3969/j.issn.1000-8535.2020.06.017

广州医药 ›› 2020, Vol. 51 ›› Issue (6): 79-82.DOI: 10.3969/j.issn.1000-8535.2020.06.017

超声引导下射频消融术治疗肝癌术后局部复发因素分析

李柱, 廖信芳, 吕海钠

广东省佛山市南海区人民医院普外二科(佛山 528200)

收稿日期:2020-03-03 出版日期:2020-11-20 发布日期:2021-11-28

Factor analysis of local recurrence of hepatocellular carcinoma after ultrasound-guided radiofrequency ablation

LI Zhu, LIAO Xinfang, LV Haina

General Surgery Department Ⅱ of Nanhai Peaple's Hospital, Foshan 528200,China

Received:2020-03-03 Online:2020-11-20 Published:2021-11-28

摘要/Abstract

摘要： 目的探讨超声引导下射频消融术治疗肝癌的资料,评价其术后局部复发的影响因素,为临床应用提供参考依据。方法回顾性分析2010年7月—2012年7月我院进行超声引导下射频消融治疗肝癌80例患者的临床资料,通过统计学软件,明确射频消融术的疗效,通过单因素分析中的χ²检验和logistic线性回归分析等方法分析射频消融治疗肝癌局部复发的主要危险因素。结果 80例肝癌患者行超声引导下射频消融术治疗的次数共为94次,12例肝癌患者接受RFA治疗的次数≥2次,94次肝癌射频消融术处理病灶共为101个,完全消融共为68例(85.0%),不完全消融12例(15.0%);所研究病例瘤体个数按≤3 cm、3～5 cm、>5 cm分组总数分别为55、34、12,其完全消融率分别为89.09%、79.41%、66.67%;运用多因素统计分析,结果显示肝硬化、肝炎史以及血管癌栓形成是影响肝癌患者射频消融术后局部复发的独立因素。结论 RFA治疗肝癌是一种疗效满意的局部微创治疗手段,肝硬化、肝炎史、血管癌栓形成是影响肝癌患者术后局部复发的独立高危因素。

关键词: 超声引导, 肝癌, 射频消融术, 局部复发

Abstract: Objective To provide reference for clinical application, we investigated the data of ultrasound-guided radiofrequency ablation RFA in the treatment of hepatocellular carcinoma and evaluated the influencing factors of local recurrence after operation. Methods The clinical data of 80 patients with hepatocellular carcinoma treated with ultrasound-guided radiofrequency ablation from July 2010 to July 2012 in our hospital were analyzed retrospectively. The efficacy of radiofrequency ablation was determined by statistical software analysis. We analyzed the main risk factors of local recurrence of hepatocellular carcinoma treated with radiofrequency ablation by χ² test and logistic linear regression analysis in univariate analysis. Results The frequency of ultrasound-guided radiofrequency ablation in 80 patients with hepatocellular carcinoma was 94 times and a total of 101 lesions were treated. Among them, 12 patients with hepatocellular carcinoma were treated with RFA more than 2 times. In 80 patients with hepatocellular carcinoma treated with RFA, 68 cases (85.0%)underwent complete ablation and 12 cases (15.0%)underwent incomplete ablation. The treated lesions were divided into 55, 34 and 12 lesions respectively, according to the size of≤ 3cm, 3 ≤ 5cm,>5cm. And the complete ablation rates were 89.09%, 79.41% and 66.67% respectively. Multivariate statistical analysis showed that liver cirrhosis, hepatitis history and vascular tumor thrombus formation were independent factors for the local recurrence of patients with hepatocellular carcinoma after radiofrequency ablation. Conclusion RFA treatment of hepatocellular carcinoma is a local minimally invasive treatment with satisfactory efficacy. Cirrhosis, hepatitis history and vascular tumor thrombosis are independent high risk factors for the local recurrence of patients with hepatocellular carcinoma.

Key words: Ultrasound-guided, Hepatocellular carcinoma, Radio-frequency ablation RFA, Local recurrence

李柱, 廖信芳, 吕海钠. 超声引导下射频消融术治疗肝癌术后局部复发因素分析[J]. 广州医药, 2020, 51(6): 79-82.

LI Zhu, LIAO Xinfang, LV Haina. Factor analysis of local recurrence of hepatocellular carcinoma after ultrasound-guided radiofrequency ablation[J]. Guangzhou Medical Journal, 2020, 51(6): 79-82.

参考文献

[1] 中华医学会外科学分会肝脏外科学组.肝细胞癌诊断与治疗路线图(修订版)[J]. 中华外科杂志,2012,50(6):505-506.
[2] RITZ J P, LEHMANN K S, REISSFELDER C, et al. Bipolar radiofrequency ablation of liver metastases during laparotomy.First clinical experiences with a new muhipolar ablation concept[J].Int J Colorectal Dis,2006(21):25-32.
[3] HUNG H H,CHIOU Y, HSIA C Y, et al.Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas[J].Clin Gastroenterol Hepatol,2011,9(1):79-86.
[4] POMPILI M, SAVIANO A, de MATTHAEIS N, et al. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma≤3 cm.Results of a multicenter Italian survey [J]. J Hepatol,2013,59(1): 89-97.
[5] KUDO M. Radiofrequency ablation for hepatocellular carcinoma:updated review in 2010[J].Oncol,2010,78 (Suppl 1):113-124.
[6] LENEIONI R, CIONI D,DEIIAPINA C,et al. Hepatocelhlar carcinoma:new optionsforimage-guided abiafion[J].J Hepatobiliary Panereat Sci,2010,17(4):399.
[7] 卢冠铭,龚艺贞,黎乐群,等. 经皮射频消融与无水乙醇注射治疗合并肝硬化的小肝癌疗效比较的Meta分析[J].重庆医学,2010,39(14):1805.
[8] 中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤学协会专业委员会,中华医学会肝病学分会肝癌组. 原发性肝癌局部消融治疗的专家共识[J].临床肿瘤学杂志,2011,16(1):70-73.
[9] LENCIONI R A,ALLGAIER H P, CIONI D,et al. Small hepatoce11u1ar carcinoma in cirrhosis:randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection[J]. Radiol,2003,228(1):235-240.
[10] KIM Y S,RHIM H,CHO 0 K, et al. Intrahepatic recurrence after percutaneous radio- frequency ablation of hepatocellular carcinoma:analysis of the pattern and risk factors[J].Eur J Radiot,2006,59(3):432-441.
[11] 石铮,杨明智.复发性肝癌的诊治[J].中华普通外科学文献电子版,2012,6(5):381-385.
[12] 孔轶,李科.原发性肝癌射频治疗后的预后影响因素分析[J].中国肿瘤临床与康复,2012,19(6):495-498.

超声引导下射频消融术治疗肝癌术后局部复发因素分析

Factor analysis of local recurrence of hepatocellular carcinoma after ultrasound-guided radiofrequency ablation

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

编辑推荐

Metrics

本文评价